共 50 条
- [32] Blindedness in clinical trials of therapies for rheumatoid arthritis: comment on the article by Bresnihan et al [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (08): : 1781 - 1782
- [33] Anticitrulline antibody assay specificity for rheumatoid arthritis: comment on the article by Schellekens et al [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (08): : 1901 - 1902
- [34] Lipoprotein(a) levels and atherosclerosis in rheumatoid arthritis: comment on the article by Asanuma et al - Reply [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (11): : 2492 - 2492
- [36] Diagnostic value of Doppler ultrasonography in rheumatoid arthritis: comment on the article by Weidekamm et al [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (02): : 676 - 677
- [37] Does treatment with glucocorticoids or with disease-modifying antirheumatic drugs reduce the rate of radiographic progression in rheumatoid arthritis? Comment on the article by Abu-Shakra et al [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (05): : 1066 - 1066
- [39] Ultrasonography of the shoulder in patients with rheumatoid arthritis: comment on the article by Hermann et al - Reply [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : 3055 - 3056
- [40] Definition of rheumatoid arthritis remission in clinical practice: comment on the article by Felson et al [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (11): : 3642 - 3642